- Home
- SYNX vs CLRB Comparison
SYNX vs CLRB Comparison
Compare SYNX & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- CLRB
- Stock Information
- Founded
- SYNX 2005
- CLRB 2002
- Country
- SYNX Israel
- CLRB United States
- Employees
- SYNX N/A
- CLRB N/A
- Industry
- SYNX
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- CLRB Health Care
- Exchange
- SYNX Nasdaq
- CLRB Nasdaq
- Market Cap
- SYNX 11.9M
- CLRB 12.5M
- IPO Year
- SYNX 2024
- CLRB N/A
- Fundamental
- Price
- SYNX $1.68
- CLRB $0.36
- Analyst Decision
- SYNX
- CLRB Hold
- Analyst Count
- SYNX 0
- CLRB 2
- Target Price
- SYNX N/A
- CLRB N/A
- AVG Volume (30 Days)
- SYNX 42.2K
- CLRB 34.3M
- Earning Date
- SYNX 05-14-2025
- CLRB 05-13-2025
- Dividend Yield
- SYNX N/A
- CLRB N/A
- EPS Growth
- SYNX N/A
- CLRB N/A
- EPS
- SYNX N/A
- CLRB N/A
- Revenue
- SYNX $9,094,000.00
- CLRB N/A
- Revenue This Year
- SYNX N/A
- CLRB N/A
- Revenue Next Year
- SYNX N/A
- CLRB N/A
- P/E Ratio
- SYNX N/A
- CLRB N/A
- Revenue Growth
- SYNX 19.14
- CLRB N/A
- 52 Week Low
- SYNX $1.65
- CLRB $0.22
- 52 Week High
- SYNX $6.49
- CLRB $3.42
- Technical
- Relative Strength Index (RSI)
- SYNX 36.84
- CLRB 61.13
- Support Level
- SYNX $1.68
- CLRB $0.23
- Resistance Level
- SYNX $1.83
- CLRB $0.69
- Average True Range (ATR)
- SYNX 0.15
- CLRB 0.05
- MACD
- SYNX 0.01
- CLRB 0.02
- Stochastic Oscillator
- SYNX 8.33
- CLRB 26.84
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.